Reclaiming Medication on the Blockchain

Research Overview

Author: Anna Hermansen
Release Date: March 31, 2020

Abstract:

The RemediChain project has emerged as a blockchain-based national database that collects drug waste data and supports the redistribution of safe, unused drugs and the safe destruction of expired or spoiled medication. The platform—a hybrid of Enterprise Ethereum incorporating Hyperledger Besu client and Istanbul Byzantine fault tolerant 2.0 with a proof-of-authority consensus mechanism—checks the quality of donations and tracks their provenance from source to destination, either to patients or to government-approved incinerators. This research explores the opportunities and implementation challenges of such a solution for stakeholders.

Copyright 2020 Blockchain Research Institute – not for distribution

Remedichain research

Related Content

Web3 in the Pharmaceutical Industry

For decades, productivity and innovation in the pharmaceutical industry have declined. It has been slow to transform digitally and culturally. This research describes how executives can lead change by harnessing Web3 technologies. The payoffs will be greater internal rates of return on drug discovery and personalized medicine, and more efficient and secure clinical trials and supply chains among other significant benefits.

Read More

Platforms for Sustainable Food Production

This brief shows how blockchain technologies, combined with mobile access to drones, sensors, satellite imagery, artificial intelligence, the Internet of Things, and other innovations, can secure our global food supply, one farm at a time. The solutions it explores focus on topsoil to mitigate the harmful effects of chemicals, aggressive tillage, monocultural crops, and climate change. The goal is to give smallholders—often the poorest farmers with less than two hectares of land in jurisdictions hardest hit by environmental and humanitarian crises—the tools and training they need for sustainable food production, transforming the long-term viability of their businesses and the future of their families in the process.

Read More
BRI
Subscribe